Digistain is a visible solution to cancer grading and prognosis developed by a team of scientists at Imperial College London. The technology can aid in objective grading tumour biopsies without human variability. It is fully compatible with current clinical processes and the image is intuitive to understand. The test can be completed in minutes vs current methods that take days.

We welcome collaborations with founders, investors and those looking to make their mark on the world.